ISRCTN68662102已完成不适用
Randomised phase II study comparing capecitabine with oral cyclophosphamide and capecitabine in patients with advanced breast cancer
Cancer Trials New Zealand (CTNZ) (New Zealand)0 个研究点目标入组 82 人开始时间: 2003年10月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 82
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women with advanced breast cancer (distant metastasis, or T4, N2 or N3, or local recurrence following mastectomy)
- •2. Measurable disease (Response Evaluation Criteria in Solid Tumors [RECIST])
- •3. Treatment with palliative intent
- •4. At least one prior course of chemotherapy for advanced disease
排除标准
- •Added as of 16/12/2008:
- •2. Less thank six months since last dose of adjuvant chemotherapy
- •3. More than one prior regimen for advanced disease
- •4. Pregnant or breast feeding
- •5. Concurrent anti-cancer therapy
- •6. Other malignancy within 5 years except adequately treated basal cell or squamous cell carcinoma of the skin or in-situ carcinoma of the cervix
研究者
相似试验
进行中（未招募）
不适用
Tesetaxel, an oral taxane, and capecitabine versus placebo and capecitabine in gastric cancerHistologically or cytologically confirmed gastric carcinoma, including gastric or gastroesophageal-junction adenocarcinomaMedDRA version: 14.1Level: LLTClassification code 10017760Term: Gastric cancer NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: PTClassification code 10017758Term: Gastric cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-022164-12-DEGenta Incorporated580
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with Cisplatin in advanced head and neck Cancer - NDAdvanced or metastatic head and neck cancerLevel: HLTClassification code 10024530EUCTR2006-003775-13-ITOSPEDALE ONCOLOGICO DI BARI43
进行中（未招募）
不适用
A phase II study of Capecitabine in combination with oral vinorelbine in advanced Breast Cancer - NDEUCTR2006-003752-38-ITOSPEDALE ONCOLOGICO DI BARI
进行中（未招募）
不适用
Prospective phase II trial using Capecitabine and Trastuzumab for therapy of female patients with cerebral metastasizing, HER2-overexpressing breast cancer - HERXECNS-metastasizing HER2-overexpressing breast cancerMedDRA version: 9.1Level: PTClassification code 10057654Term: Breast cancer femaleMedDRA version: 9.1Level: PTClassification code 10006202Term: Breast cancer stage IVEUCTR2007-003634-42-DEKlinikum der Universität München, Standort Großhadern
已完成
不适用
A randomized controlled trial comparing capecitabine 5-days-on/2-days-off regimen with conventional regimen in stage II and III colorectal cancer.StageII(high risk) and stageIII resectable colorectal cancerJPRN-UMIN000032865Wakayama Medical University110